glp 1 receptor signaling pathway The protective role of GLP-1 in neuro-ophthalmology Molecular mechanisms redirecting the GLP-1

McDonalds is the latest fast-food chain to jump on the GLP-1 train, testing new menu items to appeal to growing swaths of customers on the popular weight-loss drugs.

Nauseous after your GLP-1 shot

Treating obesity isn't just about weight lossit's about preserving health while losing weight

With the exception of Harvoni, Mounjaro and Zepbound are the only launch products ever to surpass $5 billion in sales in their first 12 months and their sales have only continued to grow

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.

FDA labeling sets GLP-1 weight-management eligibility at BMI 30+ or BMI 27+ with a comorbidity